KrisEnergy Ltd
SGX:SK3
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
K
|
KrisEnergy Ltd
SGX:SK3
|
SG |
|
Celyad Oncology SA
XBRU:CYAD
|
BE |
Balance Sheet
Balance Sheet Decomposition
KrisEnergy Ltd
KrisEnergy Ltd
Balance Sheet
KrisEnergy Ltd
| Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
35
|
122
|
248
|
51
|
29
|
38
|
66
|
69
|
51
|
45
|
|
| Cash |
35
|
122
|
248
|
0
|
0
|
38
|
66
|
69
|
0
|
0
|
|
| Cash Equivalents |
0
|
0
|
0
|
51
|
29
|
0
|
0
|
0
|
51
|
45
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
8
|
8
|
8
|
0
|
0
|
|
| Total Receivables |
29
|
35
|
66
|
0
|
66
|
64
|
60
|
37
|
46
|
33
|
|
| Accounts Receivables |
13
|
11
|
8
|
0
|
8
|
10
|
9
|
5
|
46
|
33
|
|
| Other Receivables |
15
|
23
|
58
|
0
|
58
|
54
|
51
|
32
|
0
|
0
|
|
| Inventory |
7
|
6
|
28
|
0
|
28
|
27
|
23
|
22
|
16
|
3
|
|
| Other Current Assets |
11
|
10
|
3
|
0
|
3
|
4
|
1
|
6
|
8
|
8
|
|
| Total Current Assets |
82
|
172
|
126
|
0
|
126
|
140
|
157
|
143
|
121
|
88
|
|
| PP&E Net |
233
|
241
|
874
|
0
|
874
|
726
|
570
|
485
|
440
|
386
|
|
| PP&E Gross |
233
|
241
|
874
|
0
|
874
|
726
|
570
|
485
|
0
|
0
|
|
| Accumulated Depreciation |
115
|
138
|
242
|
0
|
242
|
518
|
688
|
738
|
0
|
0
|
|
| Intangible Assets |
2
|
2
|
1
|
0
|
1
|
0
|
0
|
0
|
8
|
7
|
|
| Goodwill |
42
|
42
|
32
|
0
|
32
|
8
|
8
|
8
|
0
|
0
|
|
| Note Receivable |
1
|
0
|
0
|
0
|
0
|
12
|
4
|
4
|
4
|
4
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
1
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Assets |
42
|
42
|
32
|
0
|
32
|
8
|
8
|
8
|
0
|
0
|
|
| Total Assets |
360
N/A
|
460
+28%
|
1 033
+125%
|
0
N/A
|
1 033
N/A
|
887
-14%
|
740
-17%
|
641
-13%
|
574
-10%
|
485
-15%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
2
|
3
|
24
|
27
|
24
|
23
|
12
|
16
|
87
|
121
|
|
| Accrued Liabilities |
10
|
12
|
42
|
0
|
42
|
32
|
26
|
33
|
35
|
44
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
10
|
0
|
0
|
129
|
148
|
20
|
529
|
525
|
|
| Other Current Liabilities |
24
|
21
|
42
|
0
|
42
|
67
|
29
|
49
|
2
|
3
|
|
| Total Current Liabilities |
37
|
36
|
107
|
27
|
107
|
250
|
215
|
118
|
653
|
693
|
|
| Long-Term Debt |
80
|
81
|
305
|
0
|
305
|
288
|
276
|
439
|
1
|
66
|
|
| Deferred Income Tax |
43
|
42
|
41
|
0
|
41
|
38
|
37
|
35
|
27
|
17
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
7
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
308
|
22
|
85
|
0
|
85
|
52
|
52
|
26
|
39
|
56
|
|
| Total Liabilities |
468
N/A
|
181
-61%
|
531
+193%
|
0
N/A
|
531
N/A
|
628
+18%
|
580
-8%
|
618
+7%
|
720
+16%
|
831
+15%
|
|
| Equity | |||||||||||
| Common Stock |
0
|
1
|
2
|
0
|
2
|
2
|
2
|
2
|
2
|
2
|
|
| Retained Earnings |
106
|
124
|
225
|
0
|
225
|
471
|
571
|
708
|
878
|
1 078
|
|
| Additional Paid In Capital |
0
|
403
|
727
|
0
|
727
|
730
|
730
|
730
|
730
|
730
|
|
| Other Equity |
1
|
1
|
2
|
0
|
2
|
2
|
2
|
2
|
0
|
0
|
|
| Total Equity |
108
N/A
|
279
N/A
|
502
+80%
|
0
N/A
|
502
N/A
|
258
-49%
|
160
-38%
|
23
-86%
|
146
N/A
|
346
-137%
|
|
| Total Liabilities & Equity |
360
N/A
|
460
+28%
|
1 033
+125%
|
0
N/A
|
1 033
N/A
|
887
-14%
|
740
-17%
|
641
-13%
|
574
-10%
|
485
-15%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
820
|
820
|
1 494
|
0
|
1 494
|
1 500
|
1 503
|
1 503
|
1 503
|
1 503
|
|